Retrieve available abstracts of 14 articles: HTML format
Single Articles
June 2025
HEALEY N Stem cell therapies advance in Parkinson's disease and beyond.
Nat Med. 2025 Jun 4. doi: 10.1038/d41591-025-00036. PubMed
April 2025
O'LEARY K Progress with stem cell therapy in Parkinson's disease.
Nat Med. 2025 Apr 30. doi: 10.1038/d41591-025-00029. PubMed
March 2025
RASH BG, Ramdas KN, Agafonova N, Naioti E, et al Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's
disease: a randomized controlled phase 2a trial.
Nat Med. 2025 Mar 10. doi: 10.1038/s41591-025-03559. PubMedAbstract available
February 2025
MULLER A, Sullivan J, Schwarzer W, Wang M, et al High-efficiency base editing in the retina in primates and human tissues.
Nat Med. 2025;31:490-501. PubMedAbstract available
December 2024
O'LEARY K Stem cells reverse type 1 diabetes.
Nat Med. 2024;30:3393. PubMed
November 2024
HIV-1 remission following stem cell transplant without CCR5Delta32 mutation.
Nat Med. 2024 Nov 6. doi: 10.1038/s41591-024-03365. PubMed
October 2024
SVENDSEN SP, Svendsen CN Cell therapy for neurological disorders.
Nat Med. 2024;30:2756-2770. PubMedAbstract available
DIEZ-DIEZ M, Ramos-Neble BL, de la Barrera J, Silla-Castro JC, et al Unidirectional association of clonal hematopoiesis with atherosclerosis
development.
Nat Med. 2024;30:2857-2866. PubMedAbstract available
September 2024
SAEZ-CIRION A, Mamez AC, Avettand-Fenoel V, Nabergoj M, et al Sustained HIV remission after allogeneic hematopoietic stem cell transplantation
with wild-type CCR5 donor cells.
Nat Med. 2024 Sep 2. doi: 10.1038/s41591-024-03277. PubMedAbstract available
CHEN X, Huang Y, Huang L, Huang Z, et al A brain cell atlas integrating single-cell transcriptomes across human brain
regions.
Nat Med. 2024;30:2679-2691. PubMedAbstract available
June 2024
CHEN YB, Mohty M, Zeiser R, Teshima T, et al Vedolizumab for the prevention of intestinal acute GVHD after allogeneic
hematopoietic stem cell transplantation: a randomized phase 3 trial.
Nat Med. 2024 Jun 6. doi: 10.1038/s41591-024-03016. PubMedAbstract available
May 2024
ZINTER MS, Dvorak CC, Mayday MY, Reyes G, et al Pathobiological signatures of dysbiotic lung injury in pediatric patients
undergoing stem cell transplantation.
Nat Med. 2024 May 23. doi: 10.1038/s41591-024-02999. PubMedAbstract available
KELLY K, Bloor AJC, Griffin JE, Radia R, et al Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute
steroid-resistant graft-versus-host disease.
Nat Med. 2024 May 22. doi: 10.1038/s41591-024-02990. PubMedAbstract available
HOUOT R, Bachy E, Cartron G, Gros FX, et al Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell
lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Nat Med. 2024 May 14. doi: 10.1038/s41591-024-03053. PubMed